Antiplatelet drugs: Difference between revisions
(Created page with "'''Antiplatelet drugs''' are drugs which treat and prevent thrombosis by targeting the platelet's role in the coagulation cascade, thereby reducing the blood's tendency to form thrombi. As with anticoagulants, antiplatelets are also widely used in medicine (mostly cardiology and vascular surgery). Many patients are on antiplatelets. Unlike anticoagulants, antiplatelet drugs can be combined. When there is vascular damage, receptors on the surface of platelet...") |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Antiplatelet drugs''' are drugs which treat and prevent [[thrombosis]] by targeting the platelet's role in the [[coagulation cascade]], thereby reducing the blood's tendency to form thrombi. | '''Antiplatelet drugs''' are drugs which treat and prevent [[thrombosis]] by targeting the platelet's role in the [[coagulation cascade]], thereby reducing the blood's tendency to form thrombi. | ||
Antiplatelets are mostly used to prevent thrombosis in the arterial circulation, including the coronary circulation. | |||
As with [[anticoagulants]], antiplatelets are also widely used in medicine (mostly cardiology and vascular surgery). Many patients are on antiplatelets. Unlike anticoagulants, antiplatelet drugs can be combined. | As with [[anticoagulants]], antiplatelets are also widely used in medicine (mostly cardiology and vascular surgery). Many patients are on antiplatelets. Unlike anticoagulants, antiplatelet drugs can be combined. | ||
| Line 25: | Line 27: | ||
As you can see, antiplatelets are mostly used in case of arterial thrombosis due to [[Atherosclerosis|atherosclerotic]] cardiovascular disease. | As you can see, antiplatelets are mostly used in case of arterial thrombosis due to [[Atherosclerosis|atherosclerotic]] cardiovascular disease. | ||
<noinclude>[[Category:Pharmacology]] | <noinclude> | ||
[[Category:Pharmacology]] | |||
</noinclude> | </noinclude> | ||
Latest revision as of 12:43, 28 April 2024
Antiplatelet drugs are drugs which treat and prevent thrombosis by targeting the platelet's role in the coagulation cascade, thereby reducing the blood's tendency to form thrombi.
Antiplatelets are mostly used to prevent thrombosis in the arterial circulation, including the coronary circulation.
As with anticoagulants, antiplatelets are also widely used in medicine (mostly cardiology and vascular surgery). Many patients are on antiplatelets. Unlike anticoagulants, antiplatelet drugs can be combined.
When there is vascular damage, receptors on the surface of platelets will bind to the subendothelial collagen with the help of von Willebrand factor. This causes the platelets to change shape and release their granules, which contain thromboxane A2, ADP and serotonin.
The molecules that were released from the granules bind to receptors on other platelets and activate them too. ADP will bind to P2Y12 receptor (and the P2Y1 receptor). During platelet aggregation, the glycoprotein IIb/IIIa receptor on the platelet surface binds to fibrinogen. This aggregates the platelets by sticking them together.
By interfering with the platelet’s function in haemostasis one can also inhibit thrombosis. Different drugs act on different aspects of platelet activation and aggregation.
Types
Indications
Antiplatelets are mostly used to prevent arterial thrombosis, and in higher doses, treat them:
- Acute myocardial infarction (treatment and prophylaxis)
- Ischaemic stroke (prophylaxis)
- After percutaneous coronary intervention (to prevent thrombosis of the stent)
- Peripheral artery disease
As you can see, antiplatelets are mostly used in case of arterial thrombosis due to atherosclerotic cardiovascular disease.